Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Default mode network changes in multiple sclerosis: a link between depression and cognitive impairment?
Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.
Clonidine: 1Mg Phone Order By
Acute idiopathic polyradiculoneuritis concurrent with acquired myasthenia gravis in a West Highland white terrier dog.
Network Modeling of Crohn's Disease Incidence.
[Evaluation of white matter myelination in preterm infants using DTI and MRI].
Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration.
Association between seasonal factors and multiple sclerosis.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.
A gut (microbiome) feeling about the brain.
The emerging role of p38 MAP kinase in multiple sclerosis and its models.
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Pediatric optic neuritis.

Pages